Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03360799 · ClinicalTrials.gov registry record
Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 103
- Enrollment target
NCT03360799: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT03360799 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03360799 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
This trial studies attitudes about legalization of marijuana use in participants with cancer. Questionnaires may help doctors to learn about and compare the attitudes that patients in non-legalized and legalized states have towards the legalization of medical marijuana.
Primary Outcome
Will be defined as answering "Completely Agree" or "Slightly Agree" to the question 1 in Marijuana Survey for Patients. The number of subjects with positive attitude towards legalizing medical marijuana will be compared between patients from Texas and Arizona States using one-sided Fisher's exact test or chi-squared test, whichever appropriate. A logistic model will be used to assess the effect of state of residency, adjusting for other covariates such as gender, age, race, etc. Will employ inve
Interventions
- OTHER Questionnaire Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2017-11-17 |
| Est. Completion | 2019-08-26 |
What the finished NCT03360799 record still lists
NCT03360799 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire Administration is the first listed.
NCT03360799 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03360799 about?
NCT03360799 is a clinical study titled "Questionnaires in Assessing Attitudes About Legalization of Marijuana Use in Participants With Cancer". This trial studies attitudes about legalization of marijuana use in participants with cancer. Questionnaires may help doctors to learn about and compare the attitudes that patients in non-legalized and legalized states have towards the legalization of medical marijuana.
What is the current status of trial NCT03360799?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2017-11-17. Estimated completion is 2019-08-26.
What interventions are being tested in trial NCT03360799?
The interventions under investigation include: Questionnaire Administration (OTHER).
Who is sponsoring clinical trial NCT03360799?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI